Pacer Advisors’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $165K | Sell |
9,864
-475
| -5% | -$7.96K | ﹤0.01% | 1908 |
|
|
2025
Q1 | $159K | Buy |
10,339
+297
| +3% | +$4.57K | ﹤0.01% | 1819 |
|
|
2024
Q4 | $221K | Buy |
10,042
+396
| +4% | +$8.73K | ﹤0.01% | 1881 |
|
|
2024
Q3 | $174K | Sell |
9,646
-75
| -0.8% | -$1.35K | ﹤0.01% | 1864 |
|
|
2024
Q2 | $158K | Sell |
9,721
-475
| -5% | -$7.72K | ﹤0.01% | 1967 |
|
|
2024
Q1 | $144K | Sell |
10,196
-380
| -4% | -$5.36K | ﹤0.01% | 2262 |
|
|
2023
Q4 | $110K | Buy |
10,576
+294
| +3% | +$3.07K | ﹤0.01% | 2644 |
|
|
2023
Q3 | $105K | Buy |
10,282
+1,136
| +12% | +$11.6K | ﹤0.01% | 2205 |
|
|
2023
Q2 | $68.9K | Buy |
9,146
+552
| +6% | +$4.16K | ﹤0.01% | 2993 |
|
|
2023
Q1 | $76.1K | Buy |
8,594
+276
| +3% | +$2.44K | ﹤0.01% | 1678 |
|
|
2022
Q4 | $75.9K | Buy |
+8,318
| New | +$75.9K | ﹤0.01% | 2727 |
|
|
2022
Q1 | – | Sell |
-8,460
| Closed | -$68K | – | 2544 |
|
|
2021
Q4 | $68K | Sell |
8,460
-387
| -4% | -$3.11K | ﹤0.01% | 2111 |
|
|
2021
Q3 | $86K | Buy |
8,847
+276
| +3% | +$2.68K | ﹤0.01% | 1357 |
|
|
2021
Q2 | $85K | Hold |
8,571
| – | – | ﹤0.01% | 1358 |
|
|
2021
Q1 | $99K | Sell |
8,571
-460
| -5% | -$5.31K | ﹤0.01% | 1301 |
|
|
2020
Q4 | $87K | Sell |
9,031
-2,024
| -18% | -$19.5K | ﹤0.01% | 1379 |
|
|
2020
Q3 | $100K | Buy |
+11,055
| New | +$100K | ﹤0.01% | 1249 |
|
|
2020
Q1 | – | Sell |
-8,333
| Closed | -$82K | – | 1077 |
|
|
2019
Q4 | $82K | Buy |
8,333
+3,114
| +60% | +$30.6K | ﹤0.01% | 1158 |
|
|
2019
Q3 | $36K | Buy |
5,219
+1,760
| +51% | +$12.1K | ﹤0.01% | 1154 |
|
|
2019
Q2 | $32K | Buy |
+3,459
| New | +$32K | ﹤0.01% | 1126 |
|
|
2018
Q2 | – | Sell |
-96,859
| Closed | -$1.66M | – | 1199 |
|
|
2018
Q1 | $1.66M | Buy |
96,859
+27,526
| +40% | +$470K | 0.09% | 261 |
|
|
2017
Q4 | $1.31M | Buy |
69,333
+29,425
| +74% | +$558K | 0.09% | 292 |
|
|
2017
Q3 | $702K | Buy |
39,908
+2,090
| +6% | +$36.8K | 0.06% | 474 |
|
|
2017
Q2 | $1.26M | Buy |
+37,818
| New | +$1.26M | 0.12% | 154 |
|
|
2013
Q4 | $459K | Buy |
+7,979
| New | +$459K | 0.11% | 237 |
|